Structure

Physi-Chem Properties

Molecular Weight:  422.16
Volume:  409.396
LogP:  -0.04
LogD:  0.811
LogS:  -1.489
# Rotatable Bonds:  7
TPSA:  134.91
# H-Bond Aceptor:  9
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.493
Synthetic Accessibility Score:  4.974
Fsp3:  0.476
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.918
MDCK Permeability:  1.7163421944133006e-05
Pgp-inhibitor:  0.042
Pgp-substrate:  0.009
Human Intestinal Absorption (HIA):  0.082
20% Bioavailability (F20%):  0.867
30% Bioavailability (F30%):  0.983

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.677
Plasma Protein Binding (PPB):  55.12638854980469%
Volume Distribution (VD):  0.982
Pgp-substrate:  40.48836898803711%

ADMET: Metabolism

CYP1A2-inhibitor:  0.029
CYP1A2-substrate:  0.589
CYP2C19-inhibitor:  0.03
CYP2C19-substrate:  0.654
CYP2C9-inhibitor:  0.02
CYP2C9-substrate:  0.232
CYP2D6-inhibitor:  0.339
CYP2D6-substrate:  0.282
CYP3A4-inhibitor:  0.164
CYP3A4-substrate:  0.375

ADMET: Excretion

Clearance (CL):  7.14
Half-life (T1/2):  0.732

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.865
Drug-inuced Liver Injury (DILI):  0.041
AMES Toxicity:  0.159
Rat Oral Acute Toxicity:  0.652
Maximum Recommended Daily Dose:  0.889
Skin Sensitization:  0.131
Carcinogencity:  0.247
Eye Corrosion:  0.003
Eye Irritation:  0.023
Respiratory Toxicity:  0.965

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476842

Natural Product ID:  NPC476842
Common Name*:   (1S,3S,4R)-1-[(1S)-1,2-dihydroxyethyl]-3-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)-7,9-dimethoxy-2-oxaspiro[4.5]deca-6,9-dien-8-one
IUPAC Name:   (1S,3S,4R)-1-[(1S)-1,2-dihydroxyethyl]-3-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)-7,9-dimethoxy-2-oxaspiro[4.5]deca-6,9-dien-8-one
Synonyms:  
Standard InCHIKey:  PKAFILSFKQEGRU-GREUMRBKSA-N
Standard InCHI:  InChI=1S/C21H26O9/c1-27-15-6-11(4-5-13(15)24)19-12(9-22)21(20(30-19)14(25)10-23)7-16(28-2)18(26)17(8-21)29-3/h4-8,12,14,19-20,22-25H,9-10H2,1-3H3/t12-,14+,19-,20-/m1/s1
SMILES:  COC1=C(C=CC(=C1)[C@@H]2[C@H](C3(C=C(C(=O)C(=C3)OC)OC)[C@H](O2)[C@H](CO)O)CO)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   122182031
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0000190] Methoxyphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10900 Cinnamomum subavenium Species Lauraceae Eukaryota stems Wulai Hsiang, Taipei County, Taiwan 2005-MAY PMID[17253858]
NPO10900 Cinnamomum subavenium Species Lauraceae Eukaryota Leaves n.a. n.a. PMID[23025417]
NPO10900 Cinnamomum subavenium Species Lauraceae Eukaryota stem bark Laifeng, Hubei Province, China 2012-JUL PMID[26087384]
NPO10900 Cinnamomum subavenium Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 17900 nM PMID[26087384]
NPT113 Cell Line RAW264.7 Mus musculus Survival = 98 % PMID[26087384]
NPT113 Cell Line RAW264.7 Mus musculus Survival = 104 % PMID[26087384]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476842 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC476840
0.9638 High Similarity NPC476843
0.9638 High Similarity NPC476841
0.9 High Similarity NPC322021
0.8897 High Similarity NPC42300
0.8897 High Similarity NPC174495
0.8897 High Similarity NPC187998
0.8897 High Similarity NPC257582
0.8897 High Similarity NPC242807
0.8897 High Similarity NPC77040
0.8897 High Similarity NPC92164
0.8897 High Similarity NPC145305
0.8897 High Similarity NPC241522
0.8897 High Similarity NPC64201
0.8897 High Similarity NPC153739
0.8873 High Similarity NPC67467
0.8865 High Similarity NPC278076
0.8832 High Similarity NPC277804
0.8824 High Similarity NPC475875
0.8786 High Similarity NPC471988
0.8777 High Similarity NPC67247
0.8777 High Similarity NPC135127
0.8759 High Similarity NPC339621
0.8759 High Similarity NPC233961
0.8759 High Similarity NPC280399
0.875 High Similarity NPC264706
0.875 High Similarity NPC128208
0.875 High Similarity NPC284881
0.875 High Similarity NPC93433
0.875 High Similarity NPC474444
0.875 High Similarity NPC11258
0.875 High Similarity NPC21867
0.875 High Similarity NPC282703
0.875 High Similarity NPC184733
0.875 High Similarity NPC45774
0.875 High Similarity NPC129570
0.875 High Similarity NPC470084
0.8696 High Similarity NPC7171
0.8696 High Similarity NPC27843
0.8696 High Similarity NPC161557
0.8696 High Similarity NPC115207
0.8696 High Similarity NPC158079
0.8696 High Similarity NPC40432
0.8696 High Similarity NPC228346
0.869 High Similarity NPC163898
0.8676 High Similarity NPC118533
0.8676 High Similarity NPC165045
0.8643 High Similarity NPC244983
0.8643 High Similarity NPC287745
0.8643 High Similarity NPC237594
0.8643 High Similarity NPC476387
0.8643 High Similarity NPC326095
0.8643 High Similarity NPC249791
0.8643 High Similarity NPC119060
0.8633 High Similarity NPC181049
0.8633 High Similarity NPC239302
0.8633 High Similarity NPC4940
0.8633 High Similarity NPC207400
0.8621 High Similarity NPC50696
0.8603 High Similarity NPC206882
0.86 High Similarity NPC327225
0.8592 High Similarity NPC281780
0.8571 High Similarity NPC158331
0.8552 High Similarity NPC474966
0.854 High Similarity NPC5428
0.8531 High Similarity NPC226005
0.8529 High Similarity NPC148627
0.8521 High Similarity NPC263367
0.8521 High Similarity NPC10737
0.8521 High Similarity NPC156502
0.8521 High Similarity NPC177160
0.8521 High Similarity NPC77861
0.8521 High Similarity NPC54743
0.8521 High Similarity NPC209985
0.8521 High Similarity NPC477939
0.8521 High Similarity NPC29799
0.8514 High Similarity NPC98009
0.8514 High Similarity NPC473408
0.8514 High Similarity NPC102934
0.8514 High Similarity NPC252402
0.8511 High Similarity NPC145769
0.8507 High Similarity NPC476343
0.8507 High Similarity NPC470804
0.85 High Similarity NPC18842
0.85 High Similarity NPC175067
0.85 High Similarity NPC204215
0.8489 Intermediate Similarity NPC172673
0.8483 Intermediate Similarity NPC131971
0.8478 Intermediate Similarity NPC474178
0.8478 Intermediate Similarity NPC252307
0.8478 Intermediate Similarity NPC245826
0.8472 Intermediate Similarity NPC288452
0.8472 Intermediate Similarity NPC267291
0.8472 Intermediate Similarity NPC289690
0.8472 Intermediate Similarity NPC147379
0.8472 Intermediate Similarity NPC144284
0.8467 Intermediate Similarity NPC178048
0.8462 Intermediate Similarity NPC126206
0.8451 Intermediate Similarity NPC141765
0.8451 Intermediate Similarity NPC101624
0.8451 Intermediate Similarity NPC165155
0.8451 Intermediate Similarity NPC214729
0.8451 Intermediate Similarity NPC24490
0.8451 Intermediate Similarity NPC99572
0.8451 Intermediate Similarity NPC184938
0.8451 Intermediate Similarity NPC34103
0.8451 Intermediate Similarity NPC126409
0.8429 Intermediate Similarity NPC474017
0.8414 Intermediate Similarity NPC472711
0.8414 Intermediate Similarity NPC100675
0.8411 Intermediate Similarity NPC478268
0.8406 Intermediate Similarity NPC292056
0.8406 Intermediate Similarity NPC319625
0.8406 Intermediate Similarity NPC183181
0.8406 Intermediate Similarity NPC147821
0.8406 Intermediate Similarity NPC118787
0.8406 Intermediate Similarity NPC111247
0.8406 Intermediate Similarity NPC41706
0.8406 Intermediate Similarity NPC163332
0.8403 Intermediate Similarity NPC474640
0.8403 Intermediate Similarity NPC475757
0.8392 Intermediate Similarity NPC471664
0.8392 Intermediate Similarity NPC120852
0.8392 Intermediate Similarity NPC157554
0.8392 Intermediate Similarity NPC471665
0.8389 Intermediate Similarity NPC236166
0.8387 Intermediate Similarity NPC472962
0.8387 Intermediate Similarity NPC472961
0.8382 Intermediate Similarity NPC473451
0.8382 Intermediate Similarity NPC471693
0.8382 Intermediate Similarity NPC31344
0.8382 Intermediate Similarity NPC317769
0.8382 Intermediate Similarity NPC280704
0.838 Intermediate Similarity NPC193026
0.838 Intermediate Similarity NPC471942
0.838 Intermediate Similarity NPC49603
0.838 Intermediate Similarity NPC187616
0.838 Intermediate Similarity NPC470881
0.8378 Intermediate Similarity NPC472560
0.8369 Intermediate Similarity NPC471505
0.8369 Intermediate Similarity NPC106739
0.8358 Intermediate Similarity NPC177475
0.8358 Intermediate Similarity NPC148615
0.8358 Intermediate Similarity NPC35071
0.8356 Intermediate Similarity NPC193722
0.8356 Intermediate Similarity NPC140502
0.8356 Intermediate Similarity NPC476356
0.8356 Intermediate Similarity NPC253481
0.8356 Intermediate Similarity NPC278469
0.8356 Intermediate Similarity NPC253722
0.8356 Intermediate Similarity NPC31751
0.8355 Intermediate Similarity NPC470769
0.8355 Intermediate Similarity NPC44730
0.8345 Intermediate Similarity NPC110313
0.8345 Intermediate Similarity NPC55793
0.8333 Intermediate Similarity NPC178284
0.8333 Intermediate Similarity NPC58607
0.8333 Intermediate Similarity NPC191037
0.8333 Intermediate Similarity NPC166184
0.8322 Intermediate Similarity NPC221383
0.8322 Intermediate Similarity NPC299090
0.8322 Intermediate Similarity NPC283081
0.8322 Intermediate Similarity NPC143892
0.8322 Intermediate Similarity NPC174191
0.8322 Intermediate Similarity NPC93783
0.8322 Intermediate Similarity NPC142547
0.8322 Intermediate Similarity NPC135777
0.8322 Intermediate Similarity NPC25496
0.831 Intermediate Similarity NPC26394
0.831 Intermediate Similarity NPC6836
0.8309 Intermediate Similarity NPC85488
0.8309 Intermediate Similarity NPC209567
0.8301 Intermediate Similarity NPC25127
0.8301 Intermediate Similarity NPC287504
0.8299 Intermediate Similarity NPC477898
0.8299 Intermediate Similarity NPC185307
0.8299 Intermediate Similarity NPC470950
0.8298 Intermediate Similarity NPC470095
0.8298 Intermediate Similarity NPC470096
0.8298 Intermediate Similarity NPC65942
0.8298 Intermediate Similarity NPC248307
0.8298 Intermediate Similarity NPC469480
0.8289 Intermediate Similarity NPC267091
0.8289 Intermediate Similarity NPC476434
0.8288 Intermediate Similarity NPC83375
0.8288 Intermediate Similarity NPC471414
0.8288 Intermediate Similarity NPC263261
0.8288 Intermediate Similarity NPC224876
0.8288 Intermediate Similarity NPC87725
0.8288 Intermediate Similarity NPC311530
0.8288 Intermediate Similarity NPC470372
0.8286 Intermediate Similarity NPC170844
0.8286 Intermediate Similarity NPC86030
0.8286 Intermediate Similarity NPC5851
0.8286 Intermediate Similarity NPC476968
0.8284 Intermediate Similarity NPC135961
0.8284 Intermediate Similarity NPC24474
0.8284 Intermediate Similarity NPC320987
0.8284 Intermediate Similarity NPC311595
0.8284 Intermediate Similarity NPC181969

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476842 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8286 Intermediate Similarity NPD3027 Phase 3
0.7986 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD3620 Phase 2
0.7862 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD3882 Suspended
0.7785 Intermediate Similarity NPD7266 Discontinued
0.774 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD1613 Approved
0.7697 Intermediate Similarity NPD6190 Approved
0.7687 Intermediate Similarity NPD228 Approved
0.7628 Intermediate Similarity NPD1653 Approved
0.7626 Intermediate Similarity NPD1357 Approved
0.7622 Intermediate Similarity NPD6166 Phase 2
0.7622 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4060 Phase 1
0.7591 Intermediate Similarity NPD7157 Approved
0.7589 Intermediate Similarity NPD3705 Approved
0.7588 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD5283 Phase 1
0.7547 Intermediate Similarity NPD1934 Approved
0.7531 Intermediate Similarity NPD6234 Discontinued
0.753 Intermediate Similarity NPD3818 Discontinued
0.7516 Intermediate Similarity NPD4628 Phase 3
0.7482 Intermediate Similarity NPD5536 Phase 2
0.7466 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD8127 Discontinued
0.7438 Intermediate Similarity NPD37 Approved
0.7434 Intermediate Similarity NPD5763 Approved
0.7434 Intermediate Similarity NPD5762 Approved
0.7415 Intermediate Similarity NPD7095 Approved
0.7407 Intermediate Similarity NPD4966 Approved
0.7407 Intermediate Similarity NPD4965 Approved
0.7407 Intermediate Similarity NPD4967 Phase 2
0.7403 Intermediate Similarity NPD8166 Discontinued
0.7403 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4110 Phase 3
0.7397 Intermediate Similarity NPD2861 Phase 2
0.7397 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD3817 Phase 2
0.7333 Intermediate Similarity NPD6355 Discontinued
0.7321 Intermediate Similarity NPD7228 Approved
0.731 Intermediate Similarity NPD8651 Approved
0.7301 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD6797 Phase 2
0.7284 Intermediate Similarity NPD2801 Approved
0.7279 Intermediate Similarity NPD3021 Approved
0.7279 Intermediate Similarity NPD3022 Approved
0.7279 Intermediate Similarity NPD9494 Approved
0.7251 Intermediate Similarity NPD7251 Discontinued
0.7251 Intermediate Similarity NPD7685 Pre-registration
0.7248 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7843 Approved
0.7239 Intermediate Similarity NPD2563 Approved
0.7239 Intermediate Similarity NPD2560 Approved
0.7235 Intermediate Similarity NPD7074 Phase 3
0.7226 Intermediate Similarity NPD4237 Approved
0.7226 Intermediate Similarity NPD4236 Phase 3
0.7219 Intermediate Similarity NPD5735 Approved
0.7211 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD7808 Phase 3
0.7209 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD2684 Approved
0.7205 Intermediate Similarity NPD4380 Phase 2
0.7205 Intermediate Similarity NPD7028 Phase 2
0.7193 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7054 Approved
0.7171 Intermediate Similarity NPD6653 Approved
0.717 Intermediate Similarity NPD1512 Approved
0.7169 Intermediate Similarity NPD5494 Approved
0.7161 Intermediate Similarity NPD2424 Discontinued
0.7152 Intermediate Similarity NPD7075 Discontinued
0.7152 Intermediate Similarity NPD4140 Approved
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD3094 Phase 2
0.7135 Intermediate Similarity NPD7472 Approved
0.7126 Intermediate Similarity NPD7199 Phase 2
0.7125 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD2983 Phase 2
0.7123 Intermediate Similarity NPD2982 Phase 2
0.7115 Intermediate Similarity NPD6674 Discontinued
0.7114 Intermediate Similarity NPD4908 Phase 1
0.7105 Intermediate Similarity NPD4340 Discontinued
0.7105 Intermediate Similarity NPD230 Phase 1
0.7101 Intermediate Similarity NPD27 Approved
0.7101 Intermediate Similarity NPD2489 Approved
0.7099 Intermediate Similarity NPD6599 Discontinued
0.7086 Intermediate Similarity NPD6233 Phase 2
0.7081 Intermediate Similarity NPD3687 Approved
0.7081 Intermediate Similarity NPD3686 Approved
0.707 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD5090 Approved
0.7055 Intermediate Similarity NPD5089 Approved
0.7055 Intermediate Similarity NPD2981 Phase 2
0.7047 Intermediate Similarity NPD3018 Phase 2
0.7044 Intermediate Similarity NPD4357 Discontinued
0.7044 Intermediate Similarity NPD1511 Approved
0.7041 Intermediate Similarity NPD2970 Approved
0.7041 Intermediate Similarity NPD2969 Approved
0.7039 Intermediate Similarity NPD1558 Phase 1
0.7034 Intermediate Similarity NPD3496 Discontinued
0.703 Intermediate Similarity NPD5402 Approved
0.702 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD6798 Discontinued
0.7012 Intermediate Similarity NPD6801 Discontinued
0.7007 Intermediate Similarity NPD4749 Approved
0.7007 Intermediate Similarity NPD1358 Approved
0.7006 Intermediate Similarity NPD3060 Approved
0.7006 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.6993 Remote Similarity NPD3657 Discovery
0.6987 Remote Similarity NPD1375 Discontinued
0.6986 Remote Similarity NPD1091 Approved
0.6986 Remote Similarity NPD3092 Approved
0.6986 Remote Similarity NPD1610 Phase 2
0.6982 Remote Similarity NPD6071 Discontinued
0.6977 Remote Similarity NPD5844 Phase 1
0.6971 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7313 Approved
0.6971 Remote Similarity NPD7310 Approved
0.6971 Remote Similarity NPD7312 Approved
0.6971 Remote Similarity NPD7311 Approved
0.697 Remote Similarity NPD7096 Clinical (unspecified phase)
0.697 Remote Similarity NPD2977 Approved
0.697 Remote Similarity NPD2978 Approved
0.6968 Remote Similarity NPD5588 Approved
0.6966 Remote Similarity NPD4626 Approved
0.6966 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7473 Discontinued
0.6959 Remote Similarity NPD6696 Suspended
0.6957 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7526 Approved
0.6957 Remote Similarity NPD52 Approved
0.6957 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6559 Discontinued
0.6946 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4534 Discontinued
0.6941 Remote Similarity NPD3926 Phase 2
0.6937 Remote Similarity NPD6799 Approved
0.6934 Remote Similarity NPD3134 Approved
0.6933 Remote Similarity NPD3866 Clinical (unspecified phase)
0.6932 Remote Similarity NPD7309 Approved
0.6928 Remote Similarity NPD2238 Phase 2
0.6927 Remote Similarity NPD2490 Approved
0.6927 Remote Similarity NPD2488 Approved
0.6923 Remote Similarity NPD2161 Phase 2
0.6923 Remote Similarity NPD1247 Approved
0.6919 Remote Similarity NPD3751 Discontinued
0.6914 Remote Similarity NPD5403 Approved
0.6905 Remote Similarity NPD919 Approved
0.6903 Remote Similarity NPD4538 Approved
0.6903 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6903 Remote Similarity NPD4536 Approved
0.6901 Remote Similarity NPD2898 Approved
0.6899 Remote Similarity NPD1652 Phase 2
0.6897 Remote Similarity NPD5691 Approved
0.6894 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6892 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6892 Remote Similarity NPD5327 Phase 3
0.6884 Remote Similarity NPD290 Approved
0.6883 Remote Similarity NPD5124 Phase 1
0.6883 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6882 Remote Similarity NPD6232 Discontinued
0.6882 Remote Similarity NPD3051 Approved
0.6879 Remote Similarity NPD6004 Phase 3
0.6879 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6879 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6002 Phase 3
0.6879 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6005 Phase 3
0.6875 Remote Similarity NPD5058 Phase 3
0.6871 Remote Similarity NPD422 Phase 1
0.6867 Remote Similarity NPD5772 Approved
0.6867 Remote Similarity NPD1465 Phase 2
0.6867 Remote Similarity NPD5773 Approved
0.6865 Remote Similarity NPD2493 Approved
0.6865 Remote Similarity NPD2494 Approved
0.6863 Remote Similarity NPD4062 Phase 3
0.6863 Remote Similarity NPD2674 Phase 3
0.6857 Remote Similarity NPD7240 Approved
0.6855 Remote Similarity NPD6331 Phase 2
0.6854 Remote Similarity NPD4663 Approved
0.6853 Remote Similarity NPD6671 Approved
0.6852 Remote Similarity NPD6273 Approved
0.6845 Remote Similarity NPD4583 Approved
0.6845 Remote Similarity NPD4582 Approved
0.6835 Remote Similarity NPD5958 Discontinued
0.6831 Remote Similarity NPD1241 Discontinued
0.6828 Remote Similarity NPD3091 Approved
0.6828 Remote Similarity NPD3057 Approved
0.6826 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6821 Remote Similarity NPD2163 Approved
0.6816 Remote Similarity NPD7906 Approved
0.6815 Remote Similarity NPD6100 Approved
0.6815 Remote Similarity NPD6099 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data